Titre:
  • An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.
Auteur:Schmidt, M; Scheulen, M E; Dittrich, C; Obrist, P; Marschner, N; Dirix, Luc Y; Schmidt, M; Rüttinger, D; Schuler, M; Reinhardt, C; Awada, Ahmad
Informations sur la publication:Annals of oncology, 21, 2, page (275-282)
Statut de publication:Publié, 2010-02
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Adecatumumab
Cd326
Epcam
Human mab
Metastatic breast cancer
Mt201
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdp314
info:pii/mdp314
info:scp/77951881160
info:pmid/19633042